Madewell Women's Sweaters was recalled on July 16, 2026 in cooperation with the U.S. Consumer Product Safety Commission because the recalled sweaters violate the mandatory standard for clothing textiles, posing a risk of serious burn injuries or death..
This recall involves two styles of Madewell-branded Double V-Neck Pullover and V-Neck Cardigan women's sweaters. The sweaters were sold with or without buttons in light blue and cream and in sizes XS through L. The sweaters have long sleeves and a V-neck. "Madewell" and the size are printed on the neck label and "Style #NT611" or "Style #NT612" and "HO24" on the sewn-in side seam label.
Units affected: About 5,900
Where it was sold: Madewell and T.J. Maxx stores nationwide and online at Madewell.com from December 2024 through October 2025 for between $138 and $148.
Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.
The recalled sweaters violate the mandatory standard for clothing textiles, posing a risk of serious burn injuries or death.
Consumers should stop using the recalled sweaters immediately and contact Madewell for a full refund in the original form of payment or store credit. Consumers will be asked to destroy the sweaters by cutting them in half and send a photo of the destroyed sweater to 24-7@madewell.com. Consumers should then dispose of the destroyed product. (Remedy: Refund)
Contact: Madewell toll-free at 866-544-1937 from 9 a.m. to 9 p.m. ET Monday through Sunday, email at 24-7@madewell.com, or online at www.madewell.com/c/product-recall/ or Madewell.com and click "Recall" for more information.
Not sure what you're entitled to? Read our guide: what to do if your product is recalled.
Always confirm details on the official notice from the U.S. Consumer Product Safety Commission before acting.
View official notice →cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.